Clarus Corporation Receives Nasdaq Delisting Notice - Company Appeals Decision; Pursues Significant Transaction
26 6월 2004 - 7:22AM
PR Newswire (US)
Clarus Corporation Receives Nasdaq Delisting Notice - Company
Appeals Decision; Pursues Significant Transaction STAMFORD, Conn.,
June 25 /PRNewswire-FirstCall/ -- Clarus Corporation (NASDAQ:CLRS)
today announced that it received a letter dated June 22, 2004 from
the Nasdaq Listing Qualification Staff notifying the Company that,
based upon the Staff's review of the Company and under the
discretionary authority granted by Nasdaq Marketplace Rules 4300
and 4330(a)(3), the Company's securities will be delisted on July
1, 2004 unless the Company appeals the Staff's decision. In its
letter, the Staff noted its belief "that the Company is not
currently engaged in active business operations and is therefore a
public shell." The Company strongly disagrees with the Staff's
decision to delist the Company's securities and has appealed the
Staff's determination to the Nasdaq Listing Qualifications Panel,
although there can be no assurance that such appeal will be
successful. The appeal will stay the delisting of the Company's
securities pending the Panel's decision. Clarus, formerly a
provider of e-commerce business solutions, is seeking to redeploy
its assets and use its substantial cash and cash equivalent assets
to enhance stockholder value. The Company is currently engaged in
negotiation of a significant transaction to redeploy its assets,
however, there can be no assurance that this transaction will be
consummated. This press release contains forward-looking statements
within the meaning of the Securities Act of 1933 and the Exchange
Act of 1934. Information in this release includes Clarus' beliefs,
expectations, intentions and strategies regarding Clarus and its
future. Assumptions relating to the forward-looking statements
involve judgments with respect to, among other things, future
economic, competitive and market conditions, future business
decisions and the future decision of Nasdaq, all of which are
difficult or impossible to predict accurately and many of which are
beyond our control. Actual results could differ materially from
those projected in the forward-looking statements as a result of
certain risks including our inability to execute successfully our
planned effort to redeploy our assets to enhance stockholder value.
All forward-looking statements contained in this release are based
on information available to Clarus as of the date of this release
and Clarus assumes no obligation to update the forward-looking
statement contained herein. DATASOURCE: Clarus Corporation CONTACT:
Nigel Ekern, Chief Administrative Officer, Clarus Corporation,
+1-203-428-2000, Web site: http://www.claruscorp.com/ Company News
On-Call: http://www.prnewswire.com/comp/133360.html
Copyright
Clarus Therapeutics (MM) (NASDAQ:CLRS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Clarus Therapeutics (MM) (NASDAQ:CLRS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Clarus Therapeutics (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Clarus (MM) News Articles